Viewing 3 reply threads
  • Author
    • #13619
      Dagmar Munn

      Don’t miss this free webinar on  on Tuesday, October 29, 2019 from 1:00-2:00 PM EDT.

      Novel gene-targeted therapies are being developed for ALS and other neurodegenerative diseases. In his presentation, “Gene-targeted Therapeutics for ALS,” Timothy Miller, MD, PhD, will discuss how these drugs work and some of the research driving these clinical trials.

      The webinar is presented by the ALS Association/Northeast ALS Consortium PALS.

      Click here to register or for more information

      Or here.

      Be sure to return to this topic post and share you thoughts and comments about the information in this webinar.


    • #13644
      Diana Belland

      I watched the webinar yesterday and thought that Dr. Miller gave an excellent presentation.  And he made sure to allow 30 minutes for questions from participants.

      I wish I had taken notes or made screen shots of some of the slides so that I could make more informed comments here, but my general take-away is that gene-targeted therapeutics are very promising in the treatment of ALS.   The mouse studies showing pronounced improvement in motor function stood out for me.

      I’m looking forward to watching it again after the video recording is made available and also, Dagmar, to your comments.

      Thank you!

    • #13651
      Dagmar Munn

      For anyone who missed it, here is the link to the recording of the webinar:


    • #13676
      Dagmar Munn

      I especially appreciated the simple analogy of building a house, to explain DNA, RNA and Proteins.

Viewing 3 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account